A Biotech/pharma CRO/CMO Panel Discussion: The Nuts & Bolts for an Early Stage Biotech to Launch and Lead a Strategically Sound External Research/Outsourcing Operation

The panel this evening will present info on how to get your project or product ‘produced’ and through the necessary steps using contract resources. After brief presentations, we will engage in an interactive dialogue to help you navigate the complex and, often expensive, world.

With experienced life science cluster experts in biotech, pharma, and CRO/CMOs, join us as they share best practices from the trenches. Get questions answered on how to meet the daily challenges of picking your company’s project (sourcing manager) leader, and identifying, selecting, evaluating, managing and completing critical POC projects/studies with the right external resources (CROs/CMOs and consultants).

• Moderator: Shelley Amster, Founder and Principal, ShelleyCO, LLC; Chair, MassBio Annual CRO CMO Symposium and EAST WEST CRO CMO SUMMIT; VP TLC Incubator
• Michael Briggs, PhD, President & CSO at Woodland Pharmaceuticals, LLC, a member of the NEP Network
• Carol Gebert, PhD, Director of Business Development New England Pharma (NEP), a Network of CROs
• George Karam, President at BioAlliance – Scientific Sourcing & Consulting LLC
• Joining us is a startup as a case example:Parth Patwari, M.D., Sc.D., Chief Scientific Officer & Co-Founder of ProteoThera